Renovia
Boston
About Renovia
Renovia was a developer of prescription digital therapeutics for pelvic floor disorders. Renovia ceased operations in late 2022 after its investors conducted a strategic review including considering a sale of the company. In January 2023, substantially all the assets of the company, including its intellectual property, were sold to Axena Health, Inc.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $72.3M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2021)
- Website: renoviainc.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Life Science, Medical, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/renovia-69788 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.